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Background: Infectious crystalline keratopathy is commonly caused by Streptococcus viridans and other gram
positive organisms. We present the first case of infectious crystalline keratopathy that developed into a corneal
ulcer and grew Abiotrophia defectiva which responded well to topical and systemic antimicrobial therapy and did
not require re-grafting. A 78-year-old man underwent penetrating keratoplasty for pseudophakic bullous
keratopathy. He presented 1.5 years later with infectious crystalline keratopathy which progressed to a corneal ulcer.
The patient received topical fortified vancomycin and moxifloxacin, as well as oral moxifloxacin.
Findings: The corneal ulcer base was cultured and grew A. defectiva, or nutritionally deficient streptococcus.
Complete resolution of the corneal infiltrates was obtained within three months.
Conclusions: Nutritionally deficient streptococcus has been implicated in numerous human diseases, including
endocarditis, and is increasingly being recognized as an important pathogen. This represents the second reported
case of A. defectiva causing infectious crystalline keratopathy in humans and the first case of A. defectiva successfully
treated with antibiotics. This case shows that aggressive antibiotic therapy can be effective in A. defectiva-associated
infectious crystalline keratopathy.
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Introduction
Infectious crystalline keratopathy (ICK) was first described
in 1983 and is a rare complication following corneal trans-
plantation and chronic inflammation [1]. It is characterized
by the formation of branching and crystalline-appearing
opacities deep in the corneal stroma that are formed from
localized invasion of microorganisms without adjacent in-
flammation. Streptococcus viridans is the most common
causative organism, but other common pathogens include
Staphylococcus epidermidus, Corynebacterium, Pseudomonas
aeruginosa, and fungi [2]. We present a case of a man with
infectious crystalline keratopathy that developed into a* Correspondence: ypaulus@stanford.edu
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reproduction in any medium, provided the origcorneal ulcer and grew Abiotrophia defectiva, or nutritionally
deficient streptococcus (NDS), which responded well to top-
ical and systemic antimicrobial therapy and did not require
re-grafting. An IRB waiver was granted, and consent was
obtained from the patient. All research was performed in
accordance with the Declaration of Helsinki and all local,
regional, and national laws.
Case report
A 78-year-old man with a history of a ruptured globe,
anterior chamber intraocular lens, and pseudophakic
bullous keratopathy presented 1.5 years status-post
penetrating keratoplasty on prednisolone 1% daily. The
patient was asymptomatic, lived next to horses, and had
a penicillin allergy. Examination demonstrated a visual
acuity of 20/400 with pinhole to 20/150, which was
stable from three months prior. The graft was well-
centered with five remaining interrupted sutures and a
running suture, all of which were buried. A crystallineer. This is an Open Access article distributed under the terms of the Creative
mmons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
inal work is properly cited.
Figure 2 Slit lamp photograph two weeks after initial
presentation. This shows the resolution of the epithelial defect. The
intralamellar branches remain.
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at 9 o'clock centrally at approximately 60% depth. The
epithelium was intact and the anterior chamber quiet.
Central corneal thickness was 533 microns. He was
started on moxifloxacin ophthalmic and vancomycin for-
tified for ICK. Prednisolone was discontinued.
One week later, the patient was unable to get his
medications and reported increasing pain and redness. A
new 2.5 mm epithelial defect was present along with
moderate anterior chamber inflammation and large
keratic precipitates (Figure 1).
Results
Corneal cultures were obtained. Fortified vancomycin,
moxifloxacin, and natamycin were begun hourly, and
ciprofloxacin was given orally. The patient's symptoms
improved over the next week, and the epithelial defect
resolved (Figure 2). Over one month, the crystals had
disappeared and the patient was asymptomatic. After
three months, the patient has a visual acuity pinholing
to 20/80, resolution of the crystals, and no signs of cor-
neal graft rejection (Figure 3).
The corneal culture initially reported a few gram positive
rods. Subsequent speciation showed two colonies of
streptococcus, nutritionally deficient (fastidious), or A.
defectiva. This diagnosis was reached by colony growth on
chocolate agar plates but not blood agar, a distinctive
butterscotch-caramel odor, satellite testing where the or-
ganism was streaked on plates of Staphylococcus aureus
and noted to only grow adjacent to the S. aureus, and bio-
chemical analysis using the API Rapid Strep panel
(bioMerieux, Marcy l'Etoile, France) and Vitek GP
(bioMerieux Vitek Inc., MO, USA) using a biochemical
algorithm. Prednisolone acetate 1% daily was restarted, and
the patient remains on this medication.Figure 1 Slit lamp photograph one week after initial
presentation. An epithelial defect corneal ulcer 2.5 mm in size
overlying the area of crystalline keratopathy, which extends 5.4 mm
into the transplant, with keratic precipitates and anterior
chamber reaction.Discussion
Infectious crystalline keratopathy is a rare complication typ-
ically following penetrating keratoplasty, but it can occur in
an ungrafted cornea in patients with herpes simplex, herpes
zoster, Acanthamoeba, or local anesthetic abuse [3,4].
Three cases have been reported of patients not on topical
steroids, but instead systemically immunosuppressed [5].
Many organisms have been isolated in cases of ICK, but the
most common are gram positive aerobic streptococci which
have been reported in 42% of cases, of which S. viridans is
the most common [2]. Another 12% of cases are reported
with staphylococci as the organism isolated, including
Staphylococcus aureus and haemolyticus. Fungi have been
implicated in 8% of cases, including Candida tropicalis,
albicans, and parapsilosis, and Alternaria. Additional
organisms that have been isolated include Mycobacterium
fortuitum, Peptostreptococcus, Corynebacterium, Pseudo-
monas, and Acanthamoeba. Often, multiple organisms are
isolated.Figure 3 Slit lamp photographs taken three months after initial
presentation. This shows the resolution of the infectious crystalline
keratopathy, corneal stromal infiltrate, anterior chamber reaction,
and conjunctival injection with no signs of graft rejection.
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fastidious streptococcus or the Abiotrophia genus, has been
demonstrated to be a pathogenic organism in humans since
1961 and was first reported in cases of subacute bacterial
endocarditis [6]. NDS requires a thiol-containing com-
pound (e.g., pyridoxal) and vitamin B6 for growth. Typical
culture media do not contain these compounds, and thus
NDS are often difficult to grow. NDS is often seen as satel-
lite lesions around other bacterial organisms that secrete
pyridoxal, such as Staphylococci or Haemophilus influenzae.
NDS has primarily been reported in human cases of sub-
acute bacterial endocarditis. It has also been implicated in
pancreatic abscesses, brain abscesses, prosthetic infections,
osteomyelitis, vaginal infections, otitis externa, and superfi-
cial skin wounds. NDS are normal inhabitants of the
human oral and respiratory flora, and respond poorly to
conventional antibiotics. The Abiotrophia genus includes
four species: Abiotrophia defectiva, adiacens, balaenopterae,
and elegans. Abiotrophia adiacens has been implicated in
infectious crystalline keratopathy, endophthalmitis, and
neonatal conjunctivitis [7].
The first paper reporting NDS as a causative agent of
corneal ulcers was from the equine literature. A retrospect-
ive review of 259 eyes of corneal ulcers in horses in the
1980s in California showed 35 isolates of NDS, or 13.5% of
their cases [8]. This study also performed antimicrobial
sensitivity analysis and showed that only two cases were
resistant to penicillin. All the others were pan-sensitive to
antibiotics, and thus the authors recommended that rou-
tine sensitivities not be performed on NDS growth.
A case series of four cases of infectious crystalline
keratopathy in humans associated with NDS was
published in 1990 [9]. In this case series, additional
organisms were cultured in each case, and thus the
causative organism was unclear. One patient was status-
post penetrating keratoplasty who underwent repeat
penetrating keratoplasty for the infectious crystalline
keratopathy, which grew S. viridans, S. aureus, and NDS.
Another patient was an aphakic extended soft contact lens
wearer on fluorometholone who grew S. viridans and
NDS. Another grew S. aureus and NDS, and the last was a
case of fungal keratitis, who also grew NDS.
The first case of A. defectiva infectious crystalline
keratopathy was reported in 2010 from France in an 83-
year-old female who was 10 months status-post penetrat-
ing keratoplasty for pseudophakic bullous keratopathy [10].
The patient developed infectious crystalline keratopathy
which progressed despite topical ciprofloxacin and vanco-
mycin, and thus underwent a repeat penetrating kerato-
plasty, which showed A. defectiva.
Conclusion
This case report demonstrates the second case of A.
defectiva causing infectious crystalline keratopathy inhumans and the first case successfully treated with
antibiotics without need for re-grafting. Nutritionally de-
ficient streptococcus has been implicated in numerous
human diseases, including endocarditis, and is increas-
ingly being recognized as an important pathogen as our
ability to culture this pathogen improves and, thus,
should be considered as a potential causative organism
in corneal ulcers and infectious crystalline keratopathy.
Our case demonstrates that aggressive antibiotic therapy
with both topical-fortified antibiotics and systemic oral
antibiotics can be effective in A. defectiva-associated
infectious crystalline keratopathy.
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